EFFICACY
Clinical trials for EFFICACY explained in plain language.
Never miss a new study
Get alerted when new EFFICACY trials appear
Sign up with your email to follow new studies for EFFICACY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug HY07121 aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new drug, HY07121, in 258 adults with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe, tolerable, and can shrink tumors. Participants receive the drug by infusion, and the study will monitor side effe…
Matched conditions: EFFICACY
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 06:53 UTC
-
Could stem cells heal deadly skin wounds in kidney patients?
Disease control Recruiting nowThis early-phase study tests whether stem cells from amniotic fluid can help heal painful skin wounds (calciphylaxis) in people with chronic kidney disease. Nine participants will receive the stem cell treatment, and researchers will measure wound healing and pain levels. The goa…
Matched conditions: EFFICACY
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 06:46 UTC
-
Stem cells injected into spine to repair nerve damage
Disease control Recruiting nowThis early-stage study tests whether a single injection of lab-grown nerve cells (made from stem cells) is safe for people with a recent spinal cord injury. The cells are designed to replace damaged nerve connections. The trial involves 12 adults with injuries between the neck an…
Matched conditions: EFFICACY
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
New pill targets hard-to-treat KRAS cancers in early human trial
Disease control Recruiting nowThis study tests an experimental drug called HYP-2090PTSA in people with advanced solid tumors that have a KRAS mutation. The goal is to find a safe dose and see if the drug can shrink tumors. About 257 adults will take part in two phases: first to check safety, then to measure e…
Matched conditions: EFFICACY
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
New glasses may help kids' eyesight from getting worse
Disease control Recruiting nowThis study tests two types of special glasses lenses designed to slow the progression of nearsightedness (myopia) in children aged 6 to 14. About 120 children will wear the lenses daily for one year and have regular eye exams. The goal is to see if the lenses reduce how much the …
Matched conditions: EFFICACY
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC